|
Index of reports
> Cases resulting in a serious event (381)
> Cases with Hyperthyroidism (14)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in a serious event where reactions include hyperthyroidism.
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Indication: Brain Neoplasm
Kardegic
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
Indication: Myocardial Infarction
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-25
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-20
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-02-23
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Gastrointestinal Tube Insertion, Iodine Uptake Increased, Haemangioma, Hyperthyroidism, Thyroid Neoplasm
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Kardegic
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-02-22
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Blood Thyroid Stimulating Hormone Decreased, Cardiomyopathy, Gastrointestinal Tube Insertion, Iodine Uptake Increased, Haemangioma, Hyperthyroidism, Thyroid Neoplasm
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Kardegic
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-20
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: hospitalization
Suspect drug(s):
Mopral
Administration route: Oral
Kardegic
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Temgesic
Indication: Haemangioma
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Indication: Ischaemic Cardiomyopathy
End date: 2006-06-18
Hemigoxine
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-15
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Mopral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a physician from France on 2007-02-12
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Aspirin; Omeprazole; Temgesic; Nitroderm; Hemigoxine Nativelle
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: hospitalization
Suspect drug(s):
Omeprazole
Administration route: Oral
Aspirin
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Temgesic
Indication: Haemangioma
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Indication: Ischaemic Cardiomyopathy
End date: 2006-06-18
Hemigoxine
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from France on 2007-01-18
Patient: 83 year old male
Adverse reactions / side effects: Dysphagia, Haemangioma, Blood Thyroid Stimulating Hormone Decreased, Hyperthyroidism, Thyroid Neoplasm, Gastrointestinal Tube Insertion, Iodine Uptake Increased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Aspirin
Dosage: 1 df, qd
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Temgesic
Dosage: 0.2 mg, qd
Administration route: Oral
Indication: Brain Neoplasm
Micardis
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
End date: 2006-06-08
Hemigoxine Nativelle
Administration route: Oral
Indication: Cardiomyopathy
End date: 2006-06-08
Nitroderm
Dosage: 1 df, qd
Indication: Cardiomyopathy
End date: 2006-06-18
Other drugs received by patient: NEO-Mercazole TAB
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a physician from France on 2007-01-11
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Aspirin; Omeprazole; Temgesic; Nitroderm; Hemigoxine Nativelle
|
